Published in Stat Med on February 15, 2000
Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol (2009) 9.84
Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst (2013) 8.75
Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst (2008) 8.14
Outcomes for children and adolescents with cancer: challenges for the twenty-first century. J Clin Oncol (2010) 5.11
Obesity, abdominal obesity, physical activity, and caloric intake in US adults: 1988 to 2010. Am J Med (2014) 5.10
Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system. J Natl Cancer Inst (2011) 5.09
Prostate-cancer mortality in the USA and UK in 1975-2004: an ecological study. Lancet Oncol (2008) 4.72
Two decades of mortality trends among patients with severe sepsis: a comparative meta-analysis*. Crit Care Med (2014) 3.82
Coronary Heart Disease Mortality Declines in the United States From 1979 Through 2011: Evidence for Stagnation in Young Adults, Especially Women. Circulation (2015) 3.56
Annual Report to the Nation on the status of cancer, 1975-2008, featuring cancers associated with excess weight and lack of sufficient physical activity. Cancer (2012) 3.55
Estimating average annual per cent change in trend analysis. Stat Med (2009) 3.54
Prevalence of multiple chronic conditions among US adults: estimates from the National Health Interview Survey, 2010. Prev Chronic Dis (2013) 3.25
Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women. Breast Cancer Res (2007) 3.23
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012. Neuro Oncol (2015) 3.21
Traumatic spinal cord injury in the United States, 1993-2012. JAMA (2015) 3.16
The impact of underreported Veterans Affairs data on national cancer statistics: analysis using population-based SEER registries. J Natl Cancer Inst (2009) 3.09
Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J Clin Oncol (2013) 3.00
Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer. Cancer (2016) 2.91
Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State. J Natl Cancer Inst (2015) 2.81
Recent trends in incidence of cutaneous melanoma among US Caucasian young adults. J Invest Dermatol (2008) 2.80
Age-specific trends in incidence of noncardia gastric cancer in US adults. JAMA (2010) 2.78
A comparison of American and English hospital discharge rates for pediatric bipolar disorder, 2000 to 2010. J Am Acad Child Adolesc Psychiatry (2014) 2.57
The fall and rise of US inequities in premature mortality: 1960-2002. PLoS Med (2008) 2.43
Incidence of treatment for end-stage renal disease among individuals with diabetes in the U.S. continues to decline. Diabetes Care (2010) 2.40
Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study. Ann Rheum Dis (2014) 2.36
Spectrum of cancer risk late after AIDS onset in the United States. Arch Intern Med (2010) 2.33
Male breast cancer: a population-based comparison with female breast cancer. J Clin Oncol (2009) 2.20
Breast cancer mortality trends in England and the assessment of the effectiveness of mammography screening: population-based study. J R Soc Med (2013) 2.20
Ulcerative colitis is a disease of accelerated colon aging: evidence from telomere attrition and DNA damage. Gastroenterology (2008) 2.14
Association of A1C and fasting plasma glucose levels with diabetic retinopathy prevalence in the U.S. population: Implications for diabetes diagnostic thresholds. Diabetes Care (2009) 2.08
Impact of FDA black box advisory on antipsychotic medication use. Arch Intern Med (2010) 2.05
Trends in esophageal adenocarcinoma incidence and mortality. Cancer (2012) 2.03
Declining death rates reflect progress against cancer. PLoS One (2010) 1.91
Cancer incidence trends among Asian American populations in the United States, 1990-2008. J Natl Cancer Inst (2013) 1.90
Sex matters: secular and geographical trends in sex differences in coronary heart disease mortality. BMJ (2001) 1.90
Temporal trends in incidence of primary brain tumors in the United States, 1985-1999. Neuro Oncol (2006) 1.86
Epidemiologic contributions to recent cancer trends among HIV-infected people in the United States. AIDS (2014) 1.86
Rapid increase in breast magnetic resonance imaging use: trends from 2000 to 2011. JAMA Intern Med (2014) 1.85
Secular changes in the age-specific prevalence of diabetes among U.S. adults: 1988-2010. Diabetes Care (2013) 1.79
Epidemiology of pyrazinamide-resistant tuberculosis in the United States, 1999-2009. Clin Infect Dis (2013) 1.78
Widening of socioeconomic inequalities in U.S. death rates, 1993-2001. PLoS One (2008) 1.74
Methods for improving the quality and completeness of mortality data for American Indians and Alaska Natives. Am J Public Health (2014) 1.72
The impact of universal National Health Insurance on population health: the experience of Taiwan. BMC Health Serv Res (2010) 1.71
Public health and international drug policy. Lancet (2016) 1.71
Second primary cancers after an index head and neck cancer: subsite-specific trends in the era of human papillomavirus-associated oropharyngeal cancer. J Clin Oncol (2010) 1.70
Differences in incidence and trends of haematological malignancies in Japan and the United States. Br J Haematol (2013) 1.70
Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States. Am J Gastroenterol (2014) 1.69
SELECTING THE NUMBER OF CHANGE-POINTS IN SEGMENTED LINE REGRESSION. Stat Sin (2009) 1.69
Disparities in cancer mortality and incidence among American Indians and Alaska Natives in the United States. Am J Public Health (2014) 1.68
Hepatocellular carcinoma confirmation, treatment, and survival in surveillance, epidemiology, and end results registries, 1992-2008. Hepatology (2012) 1.68
Impact of the HIV epidemic on the incidence rates of anal cancer in the United States. J Natl Cancer Inst (2012) 1.67
A sustained decline in postmenopausal hormone use: results from the National Health and Nutrition Examination Survey, 1999-2010. Obstet Gynecol (2012) 1.67
Trends in Cancer Screening Rates among Korean Men and Women: Results from the Korean National Cancer Screening Survey, 2004-2012. Cancer Res Treat (2013) 1.67
Continued rapid increase in thyroid cancer incidence in california: trends by patient, tumor, and neighborhood characteristics. Cancer Epidemiol Biomarkers Prev (2014) 1.66
Declining childhood and adolescent cancer mortality. Cancer (2014) 1.62
Leading causes of death and all-cause mortality in American Indians and Alaska Natives. Am J Public Health (2014) 1.59
Statistics of hematologic malignancies in Korea: incidence, prevalence and survival rates from 1999 to 2008. Korean J Hematol (2012) 1.56
Worldwide Inverse Association between Gastric Cancer and Esophageal Adenocarcinoma Suggesting a Common Environmental Factor Exerting Opposing Effects. Am J Gastroenterol (2016) 1.54
Trends in Tracheostomy for Mechanically Ventilated Patients in the United States, 1993-2012. Am J Respir Crit Care Med (2015) 1.53
Age, gender, and racial differences in incidence and survival in primary CNS lymphoma. Br J Cancer (2011) 1.53
Recent breast cancer trends among Asian/Pacific Islander, Hispanic, and African-American women in the US: changes by tumor subtype. Breast Cancer Res (2007) 1.53
Constrained Total Energy Expenditure and Metabolic Adaptation to Physical Activity in Adult Humans. Curr Biol (2016) 1.51
Descriptive epidemiology of vestibular schwannomas. Neuro Oncol (2006) 1.51
Recent incidences and differential trends of thyroid cancer in the USA. Endocr Relat Cancer (2016) 1.49
Disparities in oral and pharyngeal cancer incidence, mortality and survival among black and white Americans. J Am Dent Assoc (2006) 1.48
Improved detection does not fully explain the rising incidence of well-differentiated thyroid cancer: a population-based analysis. Am J Surg (2010) 1.46
Changes in glitazone use among office-based physicians in the U.S., 2003-2009. Diabetes Care (2010) 1.46
Modelling predictions of cancer deaths in Northern Ireland. Ulster Med J (2006) 1.46
A rising trend in the incidence of advanced gastric cancer in young Hispanic men. Gastric Cancer (2016) 1.46
Trends in Dietary Supplement Use Among US Adults From 1999-2012. JAMA (2016) 1.42
Trends in Emergency Department Visits for Unsupervised Pediatric Medication Exposures, 2004-2013. Pediatrics (2015) 1.41
PD-L1 Expression Correlates with Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy in Breast Cancer. Cancer Immunol Res (2014) 1.40
Registry-based study of trends in breast cancer screening mammography before and after the 2009 U.S. Preventive Services Task Force recommendations. Radiology (2013) 1.39
Statistical methods for linking health, exposure, and hazards. Environ Health Perspect (2004) 1.37
Age-period-cohort models in cancer surveillance research: ready for prime time? Cancer Epidemiol Biomarkers Prev (2011) 1.36
Trends in Prescription Drug Use Among Adults in the United States From 1999-2012. JAMA (2015) 1.36
Trends in sepsis and infection sources in the United States. A population-based study. Ann Am Thorac Soc (2015) 1.36
Incidence trend of nasopharyngeal carcinoma from 1987 to 2011 in Sihui County, Guangdong Province, South China: an age-period-cohort analysis. Chin J Cancer (2015) 1.35
Secular trends in mortality from common cancers in the United States by educational attainment, 1993-2001. J Natl Cancer Inst (2008) 1.34
Mesothelioma incidence in 50 states and the District of Columbia, United States, 2003-2008. Int J Occup Environ Health (2013) 1.29
Trends in mortality from coronary heart and cerebrovascular diseases in the Americas: 1970-2000. Heart (2006) 1.29
Smoking-attributable cancer mortality in California, 1979-2005. Tob Control (2010) 1.29
The epidemic of non-Hodgkin lymphoma in the United States: disentangling the effect of HIV, 1992-2009. Cancer Epidemiol Biomarkers Prev (2013) 1.27
Prostate cancer incidence and mortality rates and trends in the United States and Canada. Public Health Rep (2004) 1.27
Incidence and mortality rates for colorectal cancer in Puerto Rico and among Hispanics, non-Hispanic whites, and non-Hispanic blacks in the United States, 1998-2002. Cancer (2009) 1.26
Establishing optimal selenium status: results of a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr (2010) 1.26
Suicide among Italian adolescents: 1970-2002. Eur Child Adolesc Psychiatry (2009) 1.26
Changing patterns of anal canal carcinoma in the United States. J Clin Oncol (2013) 1.23
Trends in incidence of subtrochanteric fragility fractures and bisphosphonate use among the US elderly, 1996-2007. J Bone Miner Res (2011) 1.23
Increasing thyroid cancer incidence in Lithuania in 1978-2003. BMC Cancer (2006) 1.22
Global incidence and outcome of testicular cancer. Clin Epidemiol (2013) 1.22
Did intense adverse media publicity impact on prescribing of paroxetine and the notification of suspected adverse drug reactions? Analysis of routine databases, 2001-2004. Br J Clin Pharmacol (2006) 1.21
Increasing rates of brain tumours in the Swedish national inpatient register and the causes of death register. Int J Environ Res Public Health (2015) 1.21
Use of imputed population-based cancer registry data as a method of accounting for missing information: application to estrogen receptor status for breast cancer. Am J Epidemiol (2012) 1.21
The burden of liver cancer in Asians and Pacific Islanders in the Greater San Francisco Bay Area, 1990 through 2004. Cancer (2007) 1.21
Increasing incidence of glioblastoma multiforme and meningioma, and decreasing incidence of Schwannoma (2000-2008): Findings of a multicenter Australian study. Surg Neurol Int (2011) 1.20
Breast cancer clusters in the northeast United States: a geographic analysis. Am J Epidemiol (1997) 5.73
Confidence intervals for directly standardized rates: a method based on the gamma distribution. Stat Med (1997) 4.71
Breast cancer screening among women from 65 to 74 years of age in 1987-88 and 1991. NCI Breast Cancer Screening Consortium. Ann Intern Med (1992) 4.12
Cancer surveillance series: interpreting trends in prostate cancer--part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates. J Natl Cancer Inst (1999) 3.35
Estimating medical costs from incomplete follow-up data. Biometrics (1997) 3.25
Cancer surveillance series: interpreting trends in prostate cancer--part III: Quantifying the link between population prostate-specific antigen testing and recent declines in prostate cancer mortality. J Natl Cancer Inst (1999) 2.35
Estimating lifetime and age-conditional probabilities of developing cancer. Lifetime Data Anal (1998) 2.35
Recent incidence trends for breast cancer in women and the relevance of early detection: an update. CA Cancer J Clin (1993) 1.94
Asymptomatic incidence and duration of prostate cancer. Am J Epidemiol (1998) 1.68
Increased risk of acute myocardial infarction associated with beedi and cigarette smoking in Indians: final report on tobacco risks from a case-control study. Indian Heart J (2002) 1.62
Cumulative cause-specific mortality for cancer patients in the presence of other causes: a crude analogue of relative survival. Stat Med (2000) 1.58
A method for partitioning cancer mortality trends by factors associated with diagnosis: an application to female breast cancer. J Clin Epidemiol (1994) 1.57
Fecal alpha 1-antitrypsin measurement: an indicator of Crohn's disease activity. Gastroenterology (1985) 1.53
A semi-parametric estimate of extra-Poisson variation for vital rates. Stat Med (1997) 1.53
Cancer prevalence estimates based on tumour registry data in the Surveillance, Epidemiology, and End Results (SEER) Program. Int J Epidemiol (2000) 1.44
Statistical analysis of animal cancer chemoprevention experiments. Biometrics (1993) 1.41
Prognostic significance of in situ carcinoma associated with invasive breast carcinoma. A natural experiment in cancer immunology? Cancer (1996) 1.40
Impact of screening on incidence and mortality of prostate cancer in the United States. Epidemiol Rev (2001) 1.39
Risk-adjusted cancer-incidence rates (United States). Cancer Causes Control (1996) 1.28
Role of transurethral resection of the prostate in population-based prostate cancer incidence rates. Am J Epidemiol (1999) 1.27
Disenrollment of Medicare cancer patients from health maintenance organizations. Med Care (1996) 1.27
The role of prostate-specific antigen (PSA) testing patterns in the recent prostate cancer incidence decline in the United States. Cancer Causes Control (1998) 1.25
On the use of survival analysis techniques to estimate medical care costs. J Health Econ (1999) 1.14
Bowel surveillance patterns after a diagnosis of colorectal cancer in Medicare beneficiaries. Gastrointest Endosc (2001) 1.14
Evaluating the impact of population changes in diet, physical activity, and weight status on population risk for colon cancer (United States). Cancer Causes Control (2001) 1.12
Effect of different types and amounts of fat on the development of mammary tumors in rodents: a review. Cancer Res (1997) 1.11
Partitioning linear trends in age-adjusted rates. Cancer Causes Control (2000) 1.10
Are increases in mammographic screening still a valid explanation for trends in breast cancer incidence in the United States? Cancer Causes Control (1995) 1.06
Predicting the outcome of corticoid therapy for acute ulcerative colitis. Results of a prospective, randomized, double-blind clinical trial. J Clin Gastroenterol (1987) 1.00
The effect of Medicare reimbursement for screening mammography on utilization and payment. National Cancer Institute Breast Cancer Screening Consortium. Public Health Rep (1997) 0.98
Cohort-specific risks of developing breast cancer to age 85 in Connecticut. Epidemiology (1994) 0.98
Conditional logistic regression with sandwich estimators: application to a meta-analysis. Biometrics (1998) 0.97
The lifetime risk of developing prostate cancer in white and black men. Cancer Epidemiol Biomarkers Prev (1997) 0.95
Comparison of risk estimates for selected diseases and causes of death. Prev Med (1999) 0.95
The increasing incidence of breast cancer since 1982: relevance of early detection. Cancer Causes Control (1991) 0.94
The changing face of cancer survivorship. Semin Oncol Nurs (2001) 0.93
Changing trends in U.S. prostate cancer incidence rates. J Natl Cancer Inst (1996) 0.92
Interdigital lesions and frequency of acute dermatolymphangioadenitis in lymphoedema in a filariasis-endemic area. Br J Dermatol (2006) 0.92
Increasing incidence of childhood cancer: report of 20 years experience from the greater Delaware Valley Pediatric Tumor Registry. Paediatr Perinat Epidemiol (1996) 0.92
Does size matter? Association between number of patients treated and patient outcome in metastatic testicular cancer. J Natl Cancer Inst (1999) 0.87
Prognostic factors in breast cancer--a pathological and immunological study of patients with stage 1 breast cancer. Eur J Surg Oncol (1987) 0.87
Projections of the breast cancer burden to U.S. women: 1990-2000. Prev Med (1991) 0.86
Adenocarcinoma of the uterine cervix: prognostic factors and patterns of recurrence. Gynecol Oncol (1989) 0.85
Augmentation of activity of cis-diamminedichloroplatinum(II) and mitomycin C by interferon in human malignant mesothelioma xenografts in nude mice. Cancer Res (1988) 0.84
Covariate measurement error adjustment for matched case-control studies. Biometrics (2001) 0.83
The significance of the rising incidence of breast cancer in the United States. Important Adv Oncol (1994) 0.81
Improvement in the prognosis of breast cancer from 1965 to 1984. J Clin Oncol (1998) 0.79
Fecal alpha 1-antitrypsin as a measure of Crohn's disease activity. The effect of therapy and anatomical extent of disease. J Clin Gastroenterol (1988) 0.79
Etoposide induced blood-brain barrier disruption in rats: duration of opening and histological sequelae. Cancer Res (1986) 0.79
Projection of incidence rates to a larger population using ecologic variables. Stat Med (1994) 0.79
Parametric cure models of relative and cause-specific survival for grouped survival times. Comput Methods Programs Biomed (2000) 0.79
A statistical model validating triage for the peer review process: keeping the competitive applications in the review pipeline. FASEB J (1993) 0.78
Use of the logistic organ dysfunction system to study mortality in an Indian intensive care unit. Natl Med J India (2000) 0.78
Number of helper T cells and phytohemagglutinin stimulation correlate in cancer patients. Cancer Immunol Immunother (1991) 0.76
Platelet monoamine oxidase activity and the classification of depression. Arch Gen Psychiatry (1980) 0.75
Impact of changes in catheter management on infectious complications among children with central venous catheters. Infect Control Hosp Epidemiol (1997) 0.75
Trends in the surgical treatment of ductal carcinoma in situ of the breast. Am J Surg (1992) 0.75
Physiological and electrophysiological consequences of etoposide-induced blood-brain barrier disruption. Neurosurgery (1986) 0.75
Adenocarcinoma of the cervical stump. Gynecol Oncol (1989) 0.75
Effects of etoposide-induced blood-brain barrier disruption on brain water, intracranial pressure, and cerebral vasomotor tone. Exp Neurol (1988) 0.75
Catechol-O-methyltransferase activity and classification of depression. Biol Psychiatry (1979) 0.75
Stat Bite. Impact of combination chemotherapy for advanced testicular cancer. J Natl Cancer Inst (1992) 0.75
The protective effect of experimental subarachnoid haemorrhage on sodium dehydrocholate-induced blood-brain barrier disruption. Acta Neurochir (Wien) (1986) 0.75